126 related articles for article (PubMed ID: 38505919)
1. MicroRNA let-7c-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments.
Lin T; Guo X; Du Q; Liu W; Zhong X; Wang S; Cao L
Crit Rev Immunol; 2024; 44(4):23-39. PubMed ID: 38505919
[TBL] [Abstract][Full Text] [Related]
2. Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma.
Chen W; Wang H; Shen Y; Wang S; Liu D; Zhao H; Wang G; Huang F; Wang W; Wu R; Hou L; Ye Z; Zhang X; Geng X; Yu X
Funct Integr Genomics; 2023 Feb; 23(1):56. PubMed ID: 36737507
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
4. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Huang B; Huang M; Li Q
Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
[TBL] [Abstract][Full Text] [Related]
5. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
7. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
9. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
10. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
[TBL] [Abstract][Full Text] [Related]
11. Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma.
Zhao H; Liu H; Kang W; Zhan C; Man Y; Qu T
BMC Med Genomics; 2023 Aug; 16(1):201. PubMed ID: 37626362
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2.
Cui S; Sun Y; Liu Y; Liu C; Wang J; Hao G; Sun Q
Mol Med Rep; 2017 Dec; 16(6):9494-9502. PubMed ID: 29152663
[TBL] [Abstract][Full Text] [Related]
13. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1
Bai B; Liu Y; Fu XM; Qin HY; Li GK; Wang HC; Sun SL
Oxid Med Cell Longev; 2022; 2022():7608712. PubMed ID: 36071871
[TBL] [Abstract][Full Text] [Related]
15. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
[TBL] [Abstract][Full Text] [Related]
16. Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling.
Khan H; Ni Z; Feng H; Xing Y; Wu X; Huang D; Chen L; Niu Y; Shi G
Phytomedicine; 2021 Oct; 91():153706. PubMed ID: 34517264
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway.
Zhang G; Wu YJ; Yan F
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9480-9488. PubMed ID: 31773700
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
20. The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma.
Cai L; Wang Z; Zheng H; Xu L
Anticancer Drugs; 2020 Jan; 31(1):6-18. PubMed ID: 31609764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
